Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
Saghir Akhtar, Ibrahim F. Benter, Mohammed Danjuma, et al.
Journal of drug targeting (2020) Vol. 28, Iss. 7-8, pp. 683-699
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese, Jessica Gambardella, Celestino Sardu, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 462-462
Open Access | Times Cited: 128
Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential
Hadeel Kheraldine, Ousama Rachid, Abdella M. Habib, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113908-113908
Open Access | Times Cited: 97
Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Jennifer E. Nyland, Nazia Raja‐Khan, Kerstin Bettermann, et al.
Diabetes (2021) Vol. 70, Iss. 12, pp. 2903-2916
Open Access | Times Cited: 63
Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
Samantha Cooper, Eleanor Boyle, S Jefferson, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8255-8255
Open Access | Times Cited: 58
The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, et al.
European Journal of Pharmacology (2025), pp. 177305-177305
Closed Access
Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6703-6703
Open Access | Times Cited: 39
The Benefits of Vitamin D Supplementation for Athletes: Better Performance and Reduced Risk of COVID-19
William B. Grant, Henry Lahore, Michelle S. Rockwell
Nutrients (2020) Vol. 12, Iss. 12, pp. 3741-3741
Open Access | Times Cited: 32
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
Bara A. Shraim, Moaz O. Moursi, Ibrahim F. Benter, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2
Sunil J. Wimalawansa
Biology (2024) Vol. 13, Iss. 10, pp. 831-831
Open Access | Times Cited: 3
Glucagon‐like peptide‐1 receptor agonists in the era of COVID‐19: Friend or foe?
Andrej Belančić, Andrea Kresović, Marija Dijan
Clinical Obesity (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 26
Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine
Kevin Dzobo, Haleden Chiririwa, Collet Dandara, et al.
OMICS A Journal of Integrative Biology (2020) Vol. 25, Iss. 1, pp. 13-22
Closed Access | Times Cited: 22
COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
Fatemeh Babajani, Atefeh Kakavand, Hossien Mohammadi, et al.
Health Science Reports (2021) Vol. 4, Iss. 4
Open Access | Times Cited: 19
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
Amanj Kurdi, Tanja Mueller, Natalie Weir
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Open Access | Times Cited: 12
A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
Xiaoning Wang, Chuanxi Yang, Yangyang Sun, et al.
Environment International (2020) Vol. 147, pp. 106361-106361
Open Access | Times Cited: 18
Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19
Felipe Allan da Silva da Costa, Murilo Racy Soares, Maria José Malagutti-Ferreira, et al.
Tissue Engineering and Regenerative Medicine (2021) Vol. 18, Iss. 5, pp. 735-745
Open Access | Times Cited: 17
Metainflammation in COVID-19
Mojtaba Bakhtiari, Kamyar Asadipooya
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 12, pp. 1154-1166
Closed Access | Times Cited: 11
Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study
David Meintrup, Stefan Borgmann, Karlheinz Seidl, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3855-3855
Open Access | Times Cited: 14
Advances in Targeting ACE2 for Developing COVID-19 Therapeutics
Sanika Suvarnapathaki, Divya Chauhan, Angelina Nguyen, et al.
Annals of Biomedical Engineering (2022) Vol. 50, Iss. 12, pp. 1734-1749
Open Access | Times Cited: 9
Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis
Yu Zhou, Jianbin Li, Linyao Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Advances in Angiotensin Converting Enzyme-2 and Renin Angiotensin System Against COVID 19: A Pharmacotherapy and Physicochemical Review
Suhad Hafidh
Research Review (2023)
Open Access | Times Cited: 4
WILLINGNESS TO ACCEPT AND SATISFACTION OF COVID-19 VACCINE IN EAST JAVA CULTURAL AREAS
Angga Erlando, Kemala Sari Agusti, Andre Pupung Darmawan, et al.
Jurnal Administrasi Kesehatan Indonesia (2023) Vol. 11, Iss. 1, pp. 36-47
Open Access | Times Cited: 3
Роль брадикініну в розвитку COVID-19 та інших захворювань
V.M. Pushkarev, О.І. Ковзун, Н.І. Левчук, et al.
Endokrynologia (2023) Vol. 28, Iss. 4, pp. 349-362
Open Access | Times Cited: 3
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
Samsul Arefin, Leah Hernandez, Liam J. Ward, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 8
Open Access | Times Cited: 5
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
Minela Aida Mărănducă, Daniela Maria Tănase, Cristian Tudor Cozma, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1906-1906
Open Access | Times Cited: 5
Mitigating Cardiotoxicity of Dendrimers: Angiotensin-(1-7) via Its Mas Receptor Ameliorates PAMAM-Induced Cardiac Dysfunction in the Isolated Mammalian Heart
Saghir Akhtar, Fawzi Babiker, Usman A. Akhtar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2673-2673
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top